Neurofibromatosis type 1 causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:


* [[Neurofibromatosis type 1]] due to ''[[de novo]]'' mutations of [[NF1]], occur in the absence of a family history of the disease, usually from a paternal [[Germline mutation|germline cell mutation]].<ref name="pmid9358268">{{cite journal |vauthors=Bunin GR, Needle M, Riccardi VM |title=Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues |journal=Genet. Epidemiol. |volume=14 |issue=5 |pages=507–16 |date=1997 |pmid=9358268 |doi=10.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-Y |url=}}</ref><ref name="pmid28230061" />
* [[Neurofibromatosis type 1]] due to ''[[de novo]]'' mutations of [[NF1]], occur in the absence of a family history of the disease, usually from a paternal [[Germline mutation|germline cell mutation]].<ref name="pmid9358268">{{cite journal |vauthors=Bunin GR, Needle M, Riccardi VM |title=Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues |journal=Genet. Epidemiol. |volume=14 |issue=5 |pages=507–16 |date=1997 |pmid=9358268 |doi=10.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-Y |url=}}</ref><ref name="pmid28230061" />
*Multiple ''[[de novo]]'' [[pathogenic]] varients is possible in a same family of individuals with [[neurofibromatosis type 1]].<ref name="pmid203012883" /><ref name="pmid12483293">{{cite journal |vauthors=Upadhyaya M, Majounie E, Thompson P, Han S, Consoli C, Krawczak M, Cordeiro I, Cooper DN |title=Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1 |journal=Hum. Genet. |volume=112 |issue=1 |pages=12–7 |date=January 2003 |pmid=12483293 |doi=10.1007/s00439-002-0840-1 |url=}}</ref>
* Causes for [[NF1|NF1 gene]] [[mutation]] are the following:
* Causes for [[NF1|NF1 gene]] [[mutation]] are the following:


Line 60: Line 61:
* [[Heterozygous]] pathogenic variants in ''[[NF1]] [[gene]]'' are responsible for the developement of [[neurofibromatosis 1]] disease.<ref name="pmid20301288" />
* [[Heterozygous]] pathogenic variants in ''[[NF1]] [[gene]]'' are responsible for the developement of [[neurofibromatosis 1]] disease.<ref name="pmid20301288" />
* [[Neurofibromatosis type 1]] is inherited in an autosomal dominant fashion.<ref name="urlNeurofibromatosis type 1 - Genetics Home Reference - NIH" /><ref name="pmid282300612">{{cite journal |vauthors=Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ |title=Neurofibromatosis type 1 |journal=Nat Rev Dis Primers |volume=3 |issue= |pages=17004 |date=February 2017 |pmid=28230061 |doi=10.1038/nrdp.2017.4 |url=}}</ref>
* [[Neurofibromatosis type 1]] is inherited in an autosomal dominant fashion.<ref name="urlNeurofibromatosis type 1 - Genetics Home Reference - NIH" /><ref name="pmid282300612">{{cite journal |vauthors=Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ |title=Neurofibromatosis type 1 |journal=Nat Rev Dis Primers |volume=3 |issue= |pages=17004 |date=February 2017 |pmid=28230061 |doi=10.1038/nrdp.2017.4 |url=}}</ref>
*Inherited [[neurofibromatosis type 1]] has 100% [[penetrance]].<ref name="pmid203012883" />
* Unlike many [[Autosomal dominant inheritance|autosomal dominant]] disorders, where one defective copy of a [[gene]] can produce the [[phenotype]], in [[neurofibromatosis type 1]], [[mutation]] of two copies are necessary to develope the presentation, this means that many people who inherit only one copy [[mutation]] need for a second mutation during lifetime for [[neurofibroma]]<nowiki/>s and other characteristics to arise.<ref name="urlNeurofibromatosis type 1 - Genetics Home Reference - NIH">{{cite web |url=https://ghr.nlm.nih.gov/condition/neurofibromatosis-type-1#inheritance |title=Neurofibromatosis type 1 - Genetics Home Reference - NIH |format= |work= |accessdate=}}</ref>
* Unlike many [[Autosomal dominant inheritance|autosomal dominant]] disorders, where one defective copy of a [[gene]] can produce the [[phenotype]], in [[neurofibromatosis type 1]], [[mutation]] of two copies are necessary to develope the presentation, this means that many people who inherit only one copy [[mutation]] need for a second mutation during lifetime for [[neurofibroma]]<nowiki/>s and other characteristics to arise.<ref name="urlNeurofibromatosis type 1 - Genetics Home Reference - NIH">{{cite web |url=https://ghr.nlm.nih.gov/condition/neurofibromatosis-type-1#inheritance |title=Neurofibromatosis type 1 - Genetics Home Reference - NIH |format= |work= |accessdate=}}</ref>
* Due to [[neurofibromatosis type 1]] high prevalence, other concomittant [[autosomal dominant]] disorders have been reported, such as [[Noonan syndrome]], [[multiple endocrine neoplasia type 2]], and [[Huntington disease]].<ref name="pmid19449407">{{cite journal |vauthors=Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, Rauch A |title=Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome |journal=Am. J. Med. Genet. A |volume=149A |issue=6 |pages=1263–7 |date=June 2009 |pmid=19449407 |doi=10.1002/ajmg.a.32837 |url=}}</ref>
* Due to [[neurofibromatosis type 1]] high prevalence, other concomittant [[autosomal dominant]] disorders have been reported, such as [[Noonan syndrome]], [[multiple endocrine neoplasia type 2]], and [[Huntington disease]].<ref name="pmid19449407">{{cite journal |vauthors=Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, Rauch A |title=Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome |journal=Am. J. Med. Genet. A |volume=149A |issue=6 |pages=1263–7 |date=June 2009 |pmid=19449407 |doi=10.1002/ajmg.a.32837 |url=}}</ref>
* [[Neurofibromatosis type 1]] [[mosaicism]] may also appear and be limited to one segment of the body.<ref name="pmid20301288" />
*[[Neurofibromatosis type 1]] [[mosaicism]] may also appear and be limited to one segment of the body.<ref name="pmid20301288" />
*Parents with [[Mosaic (genetics)|mosaicism]] of [[neurofibromatosis type 1]] have less 50% of chance to [[Transmittance|transmit]] the condition to its child, but if transmitted, the [[mutation]] will be present in every [[Cell (biology)|cell]] of the [[newborn]], presenting a severe variant.<ref name="pmid203012883">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Friedman JM |title= |journal= |volume= |issue= |pages= |date= |pmid=20301288 |doi= |url=}}</ref><br />
*Parents with [[Mosaic (genetics)|mosaicism]] of [[neurofibromatosis type 1]] have less 50% of chance to [[Transmittance|transmit]] the condition to its child, but if transmitted, the [[mutation]] will be present in every [[Cell (biology)|cell]] of the [[newborn]], presenting a severe variant.<ref name="pmid203012883">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Friedman JM |title= |journal= |volume= |issue= |pages= |date= |pmid=20301288 |doi= |url=}}</ref><br />



Revision as of 00:40, 25 June 2020

Neurofibromatosis type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibromatosis type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibromatosis type 1 causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibromatosis type 1 causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibromatosis type 1 causes

CDC on Neurofibromatosis type 1 causes

Neurofibromatosis type 1 causes in the news

Blogs on Neurofibromatosis type 1 causes

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Neurofibromatosis type 1 causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D.

Overview

Causes

De novo mutation

Causes for NF1 gene mutation Percentage
Small deletions 22.4%[6]
Non-sense mutations 17.5%[6]
Deletion of several exons 15.5%[6]
Missense mutations 11.8%[6]
Small insertions 11%[6]
Intronic mutations affecting RNA splicing 10.2%[6]
Deletions of the entire NF1 gene 7.2%[6]
Chromosomal anomalies 1.6%[6]
3-UTR region mutations 1.6%[6]
Large insertions 1.2%[6]

Inherited (familial)



References

  1. 1.0 1.1 1.2 1.3 Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (February 2017). "Neurofibromatosis type 1". Nat Rev Dis Primers. 3: 17004. doi:10.1038/nrdp.2017.4. PMID 28230061.
  2. 2.0 2.1 McKeever K, Shepherd CW, Crawford H, Morrison PJ (September 2008). "An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age". Ulster Med J. 77 (3): 160–3. PMC 2604471. PMID 18956796.
  3. Bunin GR, Needle M, Riccardi VM (1997). "Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues". Genet. Epidemiol. 14 (5): 507–16. doi:10.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-Y. PMID 9358268.
  4. 4.0 4.1 4.2 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Friedman JM. PMID 20301288. Vancouver style error: initials (help); Missing or empty |title= (help)
  5. Upadhyaya M, Majounie E, Thompson P, Han S, Consoli C, Krawczak M, Cordeiro I, Cooper DN (January 2003). "Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1". Hum. Genet. 112 (1): 12–7. doi:10.1007/s00439-002-0840-1. PMID 12483293.
  6. 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 "www.orpha.net" (PDF).
  7. "Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics".
  8. 8.0 8.1
  9. 9.0 9.1 "Neurofibromatosis type 1 - Genetics Home Reference - NIH".
  10. Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (February 2017). "Neurofibromatosis type 1". Nat Rev Dis Primers. 3: 17004. doi:10.1038/nrdp.2017.4. PMID 28230061.
  11. Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, Rauch A (June 2009). "Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome". Am. J. Med. Genet. A. 149A (6): 1263–7. doi:10.1002/ajmg.a.32837. PMID 19449407.

Template:WH Template:WS